About Mark de Souza
Mark de Souza is a president and chief executive officer, director at Kamal Therapeutics.
Mark de Souza first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Mark de Souza in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark de Souza works with at each company, as listed on that company's latest Form D.
Kamal Therapeutics, Inc. · Form D, Nov 24, 2025
PR
Philip Reilly
Director
JP
John Parker
Director